Pages that link to "Q43001526"

The following pages link to Hepatitis C recurrence after liver transplantation: Viral and histologic response to full-dose PEG-interferon and ribavirin. (Q43001526):

Displaying 49 items.

• Impact of new treatment options for hepatitis C virus infection in liver transplantation (Q26782017) (← links)
• Challenges of recurrent hepatitis C in the liver transplant patient (Q27011871) (← links)
• Treatment of Hepatitis C in Patients Undergoing Immunosuppressive Drug Therapy (Q28073100) (← links)
• Diagnosis, management, and treatment of hepatitis C: an update (Q29619682) (← links)
• Optimizing outcome of recurrent hepatitis C virus genotype 4 after living donor liver transplantation: moving forward by looking back. (Q33414896) (← links)
• Natural history, treatment and prevention of hepatitis C recurrence after liver transplantation: past, present and future (Q34093754) (← links)
• Antiviral treatment for hepatitis C virus infection after liver transplantation (Q34340293) (← links)
• Management of recurrent hepatitis C virus after liver transplantation (Q34589655) (← links)
• Pretransplant serum hepatitis C virus RNA levels predict response to antiviral treatment after living donor liver transplantation (Q34625761) (← links)
• An extended treatment protocol with pegylated interferon and ribavirin for hepatitis C recurrence after liver transplantation (Q35173005) (← links)
• Hepatitis C virus reinfection after liver transplantation: is there a role for direct antiviral agents? (Q35214724) (← links)
• Prevention of hepatitis C recurrence after liver transplantation: An update (Q36220172) (← links)
• Living-donor liver transplantation and hepatitis C (Q36587253) (← links)
• Telaprevir- and Boceprevir-based Triple Therapy for Hepatitis C in Liver Transplant Recipients With Advanced Recurrent Disease: A Multicenter Study (Q36760075) (← links)
• PHOENIX: A randomized controlled trial of peginterferon alfa-2a plus ribavirin as a prophylactic treatment after liver transplantation for hepatitis C virus (Q37077437) (← links)
• Interferon-free therapy for genotype 1 hepatitis C in liver transplant recipients: Real-world experience from the hepatitis C therapeutic registry and research network. (Q37552703) (← links)
• Antiviral therapy of chronic hepatitis C in patients with advanced liver disease and after liver transplantation (Q37630394) (← links)
• Systematic review: anti-viral therapy of recurrent hepatitis C after liver transplantation (Q37810315) (← links)
• Immune-mediated complications of the graft in interferon-treated hepatitis C positive liver transplant recipients (Q37818987) (← links)
• Management of hepatitis C virus infection recurrence after liver transplantation: an overview. (Q37844982) (← links)
• Diabetes mellitus following liver transplantation in patients with hepatitis C virus: risks and consequences (Q37962197) (← links)
• Spanish society of liver transplantation (SETH) consensus recommendations on hepatitis C virus and liver transplantation. (Q37973516) (← links)
• Efficacy of antiviral therapy for hepatitis C after liver transplantation with cyclosporine and tacrolimus: a systematic review and meta-analysis (Q38028429) (← links)
• Post-transplant liver biopsy and the immune response: lessons for the clinician (Q38053173) (← links)
• Recurrent hepatitis C virus infection post liver transplantation: impact of choice of calcineurin inhibitor. (Q38081919) (← links)
• Review article: the treatment of genotype 1 chronic hepatitis C virus infection in liver transplant candidates and recipients (Q38083754) (← links)
• Directly acting antivirals (DAAs) for the treatment of chronic hepatitis C virus infection in liver transplant patients: "a flood of opportunity". (Q38204468) (← links)
• Recurrent HCV after liver transplantation-mechanisms, assessment and therapy (Q38229320) (← links)
• Hepatitis C virus and liver transplantation: where do we stand? (Q38551818) (← links)
• Slower Fibrosis Progression Among Liver Transplant Recipients With Sustained Virological Response After Hepatitis C Treatment. (Q40482753) (← links)
• Urgent splenectomy after partial splenic embolization in liver-transplanted patient: a case report (Q41722932) (← links)
• Early predictors of antiviral treatment response in liver transplant recipients with recurrent hepatitis C genotype 1. (Q42232115) (← links)
• Influence of antiviral therapy in the long-term outcome of recurrent hepatitis C virus infection following liver transplantation (Q42260788) (← links)
• Hepatitis C virus sensitivity to combined antiviral therapy in liver transplant versus immunocompetent patients. (Q42990493) (← links)
• Antiviral treatment of patients with recurrent hepatitis C after liver transplantation with pegylated interferon (Q42991460) (← links)
• Factors associated with sustained virological response in liver transplant recipients with recurrent hepatitis C. (Q43001676) (← links)
• Hepatitis C immune globulin (human) for the prevention of viral recurrence after liver transplantation (Q43061683) (← links)
• Hepatitis C virus recurrence after liver transplantation: analysis of factors related to sustained viral response (Q43123071) (← links)
• Efficacy of the retreatment of hepatitis C virus infections after liver transplantation: role of an aggressive approach. (Q44051206) (← links)
• Hot topic in hepatitis C virus research: The type of immunosuppression does not matter (Q45252446) (← links)
• Hot-topic debate on hepatitis C virus: the type of immunosuppression matters (Q45364028) (← links)
• Clinical benefits of antiviral therapy in patients with recurrent hepatitis C following liver transplantation. (Q46738356) (← links)
• Treatment of genotype-1 hepatitis C recurrence after liver transplant improves survival in both sustained responders and relapsers (Q50550145) (← links)
• The prophylaxis and treatment of c virus liver disease in the liver transplantation setting. Narrative review (Q50567515) (← links)
• Liver transplantation and hepatitis C (Q58704499) (← links)
• Combinations of simple baseline variables accurately predict sustained virological response in patients with recurrent hepatitis C after liver transplantation (Q62086570) (← links)
• Facing HCV recurrence after liver transplantation: antiviral therapy response and clinical outcome (Q62804139) (← links)
• Late Deaths: What Can We Learn? (Q83771904) (← links)
• Liver transplantation (Q84135196) (← links)